The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The landscape of the intestinal microbiome amongst patients with newly diagnosed invasive breast cancer (BC) and ductal carcinoma in situ (DCIS).
 
Sarah L Sammons
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Foundation Medicine; Loxo/Lilly; Novartis; Pfizer; Relay Therapeutics; Sermonix Pharmaceuticals
Research Funding - AstraZeneca/MedImmune (Inst); Lilly (Inst); Relay Therapeutics (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
 
Thomas Kuntz
No Relationships to Disclose
 
Melissa E. Hughes
No Relationships to Disclose
 
Xochitl Morgan
No Relationships to Disclose
 
Adrienne Gropper Waks
Consulting or Advisory Role - AstraZeneca
Research Funding - Genentech (Inst); Gilead Sciences (Inst); MacroGenics (Inst); Merck (Inst)
 
Ana Christina Garrido-Castro
Honoraria - AstraZeneca; Daiichi Sankyo
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Novartis
Research Funding - 4D Path (Inst); AstraZeneca (Inst); Biovica (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Foundation Medicine (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Precede Bio (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Merck; Novartis; Roche/Genentech
 
Molly DiLullo
No Relationships to Disclose
 
Jennifer A. Ligibel
No Relationships to Disclose
 
Esther R. Ogayo
No Relationships to Disclose
 
Julia Giordano
No Relationships to Disclose
 
Sean Ryan
No Relationships to Disclose
 
Tasnim Rahman
No Relationships to Disclose
 
ROMUALDO BARROSO-SOUSA
Consulting or Advisory Role - AstraZeneca; AstraZeneca/Daiichi Sankyo; AstraZeneca/Merck; Libbs; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Libbs; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca/Daiichi Sankyo; Roche
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; AstraZeneca/Daiichi Sankyo; Gilead Sciences; MSD
 
Alyssa R. Martin
No Relationships to Disclose
 
Casey O'Quinn
No Relationships to Disclose
 
Tonia Parker
No Relationships to Disclose
 
Nancy U. Lin
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Artera; AstraZeneca; Blueprint Medicines; Daiichi Sankyo; Eisai; Johnson & Johnson/Janssen; Menarini; Olema Pharmaceuticals; Pfizer; Seagen
Research Funding - Genentech (Inst); Merck (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst); Seagen (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases; Royalties, Jones & Bartlett
Travel, Accommodations, Expenses - Olema Pharmaceuticals
 
Elizabeth A. Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Alight Sciences; AstraZeneca; BioNTech SE; Merck; Moderna Therapeutics
Research Funding - Gilead Sciences (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck Sharpe and Dohme
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Roche/Genentech
 
Sara M. Tolaney
Consulting or Advisory Role - AADi; ARC Therapeutics; Artios Biopharmaceuticals; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Blueprint Medicines; Bristol-Myers Squibb; CytomX Therapeutics; Daiichi Sankyo; eFFECTOR Therapeutics; Eisai; Genentech; Hengrui Pharmaceutical (USA); Immunomedics/Gilead; Incyte; Infinity Pharmaceuticals; Jazz Pharmaceuticals; Lilly; Menarini Group; Merck; Natera; Novartis; OncXerna Therapeutics; Pfizer; Reveal Genomics; Sanofi; Seagen; Sumitovant Biopharma; Systimmune; Tango Therapeutics; Umoja Biopharma; Zentalis; Zetagen; Zymeworks
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Novartis (Inst); OncoPep (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Sanofi